Balance Sheet
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Liabilities and Shareholders Equity (2019 - 2021)

Legend Biotech (LEGN) has disclosed Liabilities and Shareholders Equity for 3 consecutive years, with $1.1 billion as the latest value for Q4 2021.

  • For the quarter ending Q4 2021, Liabilities and Shareholders Equity rose 55.03% year-over-year to $1.1 billion, compared with a TTM value of $1.1 billion through Dec 2024, down 39.21%, and an annual FY2021 reading of $1.1 billion, up 55.03% over the prior year.
  • Liabilities and Shareholders Equity was $1.1 billion for Q4 2021 at Legend Biotech, up from $722.1 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $1.1 billion in Q4 2021 and bottomed at $287.7 million in Q4 2019.
  • Average Liabilities and Shareholders Equity over 3 years is $709.8 million, with a median of $722.1 million recorded in 2020.
  • The sharpest move saw Liabilities and Shareholders Equity skyrocketed 150.98% in 2020, then surged 55.03% in 2021.
  • Year by year, Liabilities and Shareholders Equity stood at $287.7 million in 2019, then surged by 150.98% to $722.1 million in 2020, then skyrocketed by 55.03% to $1.1 billion in 2021.
  • Business Quant data shows Liabilities and Shareholders Equity for LEGN at $1.1 billion in Q4 2021, $722.1 million in Q4 2020, and $287.7 million in Q4 2019.